Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
At least one thing seems to be sure: Mr. Kempers did not exercise his options to sell the shares until tomorrow.
Wondering how long it will take to inform us about the outcome and further steps.
And I am still surprised about the shortness of the bid process of only 16 days. Even for experts in this field it should not be a simple task to understand what Mymetics has and value that for a bid in that short time span. Perhaps Mr. Kempers talked to many potentially interested companies ahead of filing the 8-K and it already was clear who is interested really. Maybe this is just the auction. But nothing seems to be publicly available - but I did not check ebay.
It's exciting to own a such big lotto ticket which can end in a big range from 0 to unknown.
My feeling is that I am unsufficiently informed.
We all know results from testing the HIV vaccine are pending. And how could it be any different when the company actively seeks for a sale of the company that Mr. Kempers knows the results? I think nobody would try that in this situation. Therefore I am pretty sure Mr. Kempers knows either about poor results and they just want to sell the rest of the company (in particular the birch pollen project, probably) or he knows about a good outcome from the HIV tests and they think it's an ideal situation to sell the company instead of financing making the vaccine ready for the market.
In either way I think we should know the results, because potential buyers will surely get them. So, why don't we get them? Are these secret?
In any case this lack of information prevents me from making profound investment decisions.
My impression is that we got contradictory signs. Recently I wrote it: On the one hand Mr. Kempers executes options (I think he paid for the shares. Hope I am right in this) and on the other hand many other options don't get touched. I don't know what will happen to these in the case of a sale of the company. Will they expire or will the owners be compensated? If the latter is true, I wouldn't be concerned and Mr. Kempers exercise may have been a friendly hint to us shareholders.
Everything depends on the HIV vaccine, now. The company has immense debt. If I am right, everything below about 80 million would mean a total loss for us. Probably many shareholders would need at least 100 million to not loose money.
To get to the point: I know nothing and can't make decisions.
I am curious about todays trading as well.
At least we know now Mr. Kempers is not preparing to file for bankrupcy.
Unfortunately I have no detailed list about the options. But 5000000 * $0.023 is $115000.
And since exercise price is $0.023 (according to the form 4) and options with that price expire in average in 3.3 years (according to the 10K from 12/31/2021) Mr. Kempers was probably not forced to exercise now.
But there are many more options outstanding with a probably much shorter time till expiration.
Johnson & Johnson failed with their HIV vaccine.
Mr. Kempers, are "we" better?
New board member: Marcel B. Rüegg.
I don't know what he may contribute. Perhaps financing or sale of the company.
In German: https://www.brauneis-partner.at/ueber-uns
Perhaps 1.1/share?
Buyout of Bioasis, not for cash but for shares.
I do not yet understand what that means in cash.
https://www.otcmarkets.com/stock/BIOAF/news/Bioasis-Technologies-Inc-Announces-Merger-with-Midatech-Pharma-plc?id=383691
Trading is halted. I see no reason.
Didn't watch them anymore, but: nice.
We should initiate a crowdfunding campaign with the subject: "Donate for a dose of adrenaline in favor of Mymetics."
Yesterday I received the payment. Hope you all got it as well.
No, they did not.
In addition on 24th of Oct. the transfer agent wrote to me:
Meanwhile I got an answer about payment from Reddington Partners. Apparently only a part of shareholders received the distribution. They wrote payment "Should happen in short order."
Granting options already works in that company.
Got the information from the company that "The company’s transfer agent is handling the cash distribution". I contacted them but they didn't reply.
No, I received nothing.
I think that's what they promised to pay as cash distribution to the old shareholders from these $400k. But I don't know how that was calculated. And I don't want to do the work to calculate it myself just because of these 25 cents. I am disappointed since nothings seems to go forward with the shell.
In regard of this statement from the 10-Q: "As of June 17, 2022, Anergis SA has entered into bankruptcy proceedings."
It's interesting Mr. Kempers still cares about what's happening to the company Anergis and not only the related intellectual property (possibly in other hands). I don't know but that could mean the IP is still owned by Anergis. And it could mean Mymetics is circling over the carrion to pick up the fillet.
For all shares transaction code P is listed. P means: "Open market or private purchase of non-derivative or derivative security". In my opinion that clearly means he spent money on these shares.
Mr. Kempers, do you see current share price? It's high time for buyout news.
That's what I dream of.
I don't attach too much importance to share price currently, while not liking declining ones, of course. But almost everyone concerned with this stock knows that Mr. Kempers is trying to reach a turning point for the company, and I suppose this will be the company's sale. Share price should only show nervosity of shareholders currently.
Just my guess: He will try to get that much money that debt can be redeemed and shareholders get a bit more than current share price. In addition to this he probably will try to get some "options" for milestones in further development of Mymetic's IP by the buying company.
CRTG participates at six events: https://www.otcmarkets.com/stock/CRTG/news/The-Coretec-Group-to-Participate-in-EV-Conferences-and-Increase-Awareness-of-Endurion-Battery-Program?id=360258
I am really wondering how far they are in battery development and therefore what they could tell the potential partners and customers.
I don't like to write this, but my impression is that insiders want to sell the company just to get back the money they did put in. That could be the reason for the weak reaction of share price to the announcement in recent 10-Q.
My guess is $0.08 to $0.25. And I tend to overestimate such numbers, so I have to look at the lower end.
I am afraid I am realistic and that disappoints (and shocks) me a bit when I remember how long I had my money in this company. Nevertheless $0.08 would mean a profit for me.
Cheap seems to be over. Wanted more at 0.1.
The quartery report seemed to be good to me.
I don't think todays PR is bad. Nevertheless -14.2%.
Thanks!
Thank you!
Unfortunately I can't find that information in the filings. Do you have readily available a reference where I can find it?
No, there's no new person. He just listed for every company the name of the controlling person. These names are well known, here.
Yesterday, Mr. Kempers again filed an updated OTCQB certification. I think the only difference to the one of 04/05/2022 is that for all notes holders a person has been added.
Unfortunately I am not familiar with such things/obligations. Why do the work to make such an update... Wasn't that information necessary in the past, but now... A bit strange.
Instead of that update I would prefer Mr. Kempers to register here and tell us about that 11 million reduction in float.
Not one million but to be exact 11025477.
Mr. Kempers is still working on his LinkedIn account. Now he is a "CEO and Non Exec Director - Transformation, Scale-up, Business Strategy and Financial Control".
In my opinion he can't be CEO and a "Non Exec Director" in the same company. Is Mymetics to be bought out by a company he works as "Non Exec Director"? I think it could be possible.
I could imagine and I would like it. Only 1 Billion market cap would do that. But we finally need some success. My guess is that Mr. Kempers does everything to achieve organic growth to not dillute his own shares, and probably the big stake holders want this as well. But that makes this company so slow. I am afraid this is so slow that we will be overhauled everywhere the company could have success in. Now he writes something about 2024 in regard of HIV, and that is probably meant if nothing goes wrong. I should ask Mr. Burkhard if Mymetics is just a hobby of him, but he wont reply.
There's a new OTCQB Certification available at otcmarkets.com.
Found a few changes.
Public float decreased significantly to 80,188,521. I don't know a reason for that.
News at company website
https://www.mymetics.com/media-center/publication-nature-scientific-reports/
regarding SARS-CoV-2:
https://www.nature.com/articles/s41598-022-07590-w
Mr. Kempers is working hard on his Linkedin account. Now he writes: "CEO and Director - Transformation, Scale-up, Business Strategy and Financial Control"
Previous was: "CEO and Director - Transformation, Scale-up and Restructuring"
That means, he is done with "Restructuring" and now works on "Business Strategy and Financial Control".
I eagerly would like to know his definitions of all these terms.
I read this as Coretec wants to develop a battery and not only supply CHS.
I can't believe my eyes!
NEWS!
Unfortunately I am not able to scientifically rate that, but it seems to me to be not really positive.